{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:09:58Z","timestamp":1790222998476,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T00:00:00Z","timestamp":1617667200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatitis C virus reinfections in HIV-positive men-who-have-sex-with-men (MSM) challenge the effectiveness of antiviral treatment. To fight this problem, an adapted sexual risk reduction intervention was implemented within a hepatitis C treatment trial. Following this, the current study had two aims and describes 1) how the program was received by participants; and 2) their responses to the program regarding sexual risk taking. Based on the participants\u2019 input, we hoped to judge the intervention\u2019s potential for scale-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Seventeen participants who received the sexual risk reduction intervention in addition to hepatitis C treatment were recruited for semi-structured interviews six to 12 months post-intervention. We evaluated the responses via reflexive thematic analysis and applied the concept of sense-making.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p><jats:italic>Giving hepatitis C a place and living without it again<\/jats:italic> illustrates how participants received the program and how their experiences were altered by the impact of sense-making. Based on their responses, we allocated participants to three groups: 1. <jats:italic>Avoid risks: get rid of hepatitis C for life<\/jats:italic>. For these men, hepatitis C remained a life-threatening disease: they actively modified their risk behavior and felt supported by the intervention in maintaining their behavioral changes. 2. <jats:italic>Minimize risks: live as long as possible without hepatitis C.<\/jats:italic> In contrast to group 1, these men saw hepatitis C as a manageable disease. The intervention facilitated reflection on risks and how to develop behavioral changes that suited them individually. 3. <jats:italic>Accept risks; live with the risk of hepatitis C.<\/jats:italic> These men perceived behavioral changes as much more difficult than \u201ceasy\u201d medical treatment. They expected to either undergo repeated rounds of treatment or stay HCV re-infected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>These results illustrate the diversity of men\u2019s responses and their decisions regarding sexual risk behavior after participating in a combination of antiviral treatment and a sexual risk reduction intervention. Two major aspects were identified: 1) Teachable moments, particularly at the time of diagnosis\/treatment, could offer an opportunity to develop openness for behavioral change; 2) adapting sexual risk reduction interventions to sense-making patterns could help to improve its effectiveness. Support for reducing infection risk and raising awareness of preventative measures are additional benefits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Clinical Trial Number: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02785666\">NCT02785666<\/jats:ext-link>, 30.05.2016.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06003-z","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T11:02:39Z","timestamp":1617706959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV\/HCV co-infected men who have sex with men: a reflexive thematic analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Patrizia","family":"K\u00fcnzler-Heule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Fierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel Jeremias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Rasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmina","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Kocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Engberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana","family":"N\u00f6stlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Lehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kouyos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique Laurent","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunja","family":"Nicca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,6]]},"reference":[{"key":"6003_CR1","unstructured":"Situationsanalyse zu Hepatitis B und C in der Schweiz [https:\/\/www.bag.admin.ch\/bag\/de\/home\/service\/publikationen\/forschungsberichte\/forschungsberichte-uebertragbare-krankheiten\/situationsanalyse-hepatitis.html]."},{"issue":"3","key":"6003_CR2","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/liv.13528","volume":"38","author":"C Beguelin","year":"2018","unstructured":"Beguelin C, Suter A, Bernasconi E, Fehr J, Kovari H, Bucher HC, et al. Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV cohort study. Liver Int. 2018;38(3):424\u201331. https:\/\/doi.org\/10.1111\/liv.13528.","journal-title":"Liver Int"},{"key":"6003_CR3","first-page":"w14093","volume":"145","author":"G Wandeler","year":"2015","unstructured":"Wandeler G, Dufour JF, Bruggmann P, Rauch A. Hepatitis C: a changing epidemic. Swiss Med Wkly. 2015;145:w14093.","journal-title":"Swiss Med Wkly"},{"issue":"1","key":"6003_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3851\/IMP2975","volume":"21","author":"V Soriano","year":"2016","unstructured":"Soriano V, Labarga P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benitez-Gutierrez L, et al. Hepatitis C cure with antiviral therapy--benefits beyond the liver. Antivir Ther. 2016;21(1):1\u20138. https:\/\/doi.org\/10.3851\/IMP2975.","journal-title":"Antivir Ther"},{"key":"6003_CR5","doi-asserted-by":"publisher","unstructured":"Mocroft A, Lundgren J, Gerstoft J, Rasmussen LD, Bhagani S, Aho I, et al. Clinical outcomes in persons Coinfected with human immunodeficiency virus and hepatitis C virus: impact of hepatitis C virus treatment. Clin Infect Dis. 2019;70(10):2131. https:\/\/doi.org\/10.1093\/cid\/ciz601.","DOI":"10.1093\/cid\/ciz601"},{"key":"6003_CR6","unstructured":"Combating hepatitis B and C to reach elimination by 2030 [https:\/\/www.who.int\/hepatitis\/publications\/hep-elimination-by-2030-brief\/en\/]."},{"issue":"1 Suppl","key":"6003_CR7","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.jhep.2016.07.012","volume":"65","author":"H Midgard","year":"2016","unstructured":"Midgard H, Weir A, Palmateer N, Lo Re V 3rd, Pineda JA, Macias J, et al. HCV epidemiology in high-risk groups and the risk of reinfection. J Hepatol. 2016;65(1 Suppl):S33\u201345. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.012.","journal-title":"J Hepatol"},{"key":"6003_CR8","doi-asserted-by":"crossref","unstructured":"Ingiliz P, Wehmeyer MH, Boesecke C, Schulze Zur Wiesch J, Schewe K, Lutz T, et al. Reinfection with the hepatitis C virus in men who have sex with men after successful treatment with direct-acting antivirals in Germany: current incidence rates compared with rates during the interferon era. Clin Infect Dis. 2019;71(5):1248.","DOI":"10.1093\/cid\/ciz949"},{"key":"6003_CR9","doi-asserted-by":"publisher","unstructured":"Berenguer J, Gil-Martin A, Jarrin I, Montes ML, Dominguez L, Aldamiz-Echevarria T, et al. Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV\/hepatitis C virus coinfected individuals. AIDS. 2019;33(4):685\u20139. https:\/\/doi.org\/10.1097\/QAD.0000000000002103.","DOI":"10.1097\/QAD.0000000000002103"},{"issue":"6","key":"6003_CR10","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/hep.28769","volume":"64","author":"L Salazar-Vizcaya","year":"2016","unstructured":"Salazar-Vizcaya L, Kouyos RD, Zahnd C, Wandeler G, Battegay M, Darling KE, et al. Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: modeling the effect of behavioral and treatment interventions. Hepatology. 2016;64(6):1856\u201369. https:\/\/doi.org\/10.1002\/hep.28769.","journal-title":"Hepatology"},{"issue":"3","key":"6003_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0038-1666841","volume":"38","author":"JV Lazarus","year":"2018","unstructured":"Lazarus JV, Safreed-Harmon K, Thursz MR, Dillon JF, El-Sayed MH, Elsharkawy AM, et al. The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations. Semin Liver Dis. 2018;38(3):181\u201392. https:\/\/doi.org\/10.1055\/s-0038-1666841.","journal-title":"Semin Liver Dis"},{"key":"6003_CR12","doi-asserted-by":"publisher","unstructured":"Swiss HIV Cohort Study, Schoeni-Affolter F, Ledergerber B, Rickenbach M, Rudin C, Gunthard HF, et al. Cohort profile: the Swiss HIV cohort study. Int J Epidemiol. 2010;39(5):1179\u201389. https:\/\/doi.org\/10.1093\/ije\/dyp321.","DOI":"10.1093\/ije\/dyp321"},{"key":"6003_CR13","doi-asserted-by":"publisher","unstructured":"Braun DL, Hampel B, Ledergerber B, Grube C, Nguyen H, Kunzler-Heule P, et al. A treatment as prevention trial to eliminate hepatitis C among men who have sex with men living with HIV in the Swiss HIV cohort study. Clin Infect Dis. 2020;1:ciaa1124. https:\/\/doi.org\/10.1093\/cid\/ciaa1124.","DOI":"10.1093\/cid\/ciaa1124"},{"key":"6003_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijid.2016.05.030","volume":"49","author":"DP Chan","year":"2016","unstructured":"Chan DP, Sun HY, Wong HT, Lee SS, Hung CC. Sexually acquired hepatitis C virus infection: a review. Int J Infect Dis. 2016;49:47\u201358. https:\/\/doi.org\/10.1016\/j.ijid.2016.05.030.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"6003_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/COH.0b013e32834b4974","volume":"6","author":"M Danta","year":"2011","unstructured":"Danta M, Rodger AJ. Transmission of HCV in HIV-positive populations. Curr Opin HIV AIDS. 2011;6(6):451\u20138. https:\/\/doi.org\/10.1097\/COH.0b013e32834b4974.","journal-title":"Curr Opin HIV AIDS"},{"key":"6003_CR16","doi-asserted-by":"publisher","unstructured":"Schmidt AJ, Rockstroh JK, Vogel M, An der Heiden M, Baillot A, Krznaric I, et al. Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study. PLoS One. 2011;6(3):e17781. https:\/\/doi.org\/10.1371\/journal.pone.0017781.","DOI":"10.1371\/journal.pone.0017781"},{"issue":"3","key":"6003_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s15010-016-0975-y","volume":"45","author":"V Ghisla","year":"2016","unstructured":"Ghisla V, Scherrer AU, Nicca D, Braun DL, Fehr JS. Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis. Infection. 2016;45(3):309.","journal-title":"Infection"},{"key":"6003_CR18","doi-asserted-by":"publisher","unstructured":"van Sighem A, Vidondo B, Glass TR, Bucher HC, Vernazza P, Gebhardt M, et al. Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. PLoS One. 2012;7(9):e44819. https:\/\/doi.org\/10.1371\/journal.pone.0044819.","DOI":"10.1371\/journal.pone.0044819"},{"key":"6003_CR19","doi-asserted-by":"publisher","unstructured":"Apers L, Vanden Berghe W, De Wit S, Kabeya K, Callens S, Buyze J, et al. Risk factors for HCV acquisition among HIV-positive MSM in Belgium. J Acquir Immune Defic Syndr. 2015;68(5):585\u201393. https:\/\/doi.org\/10.1097\/QAI.0000000000000528.","DOI":"10.1097\/QAI.0000000000000528"},{"issue":"17","key":"6003_CR20","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1097\/QAD.0000000000000834","volume":"29","author":"H Hagan","year":"2015","unstructured":"Hagan H, Jordan AE, Neurer J, Cleland CM. Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men. AIDS. 2015;29(17):2335\u201345. https:\/\/doi.org\/10.1097\/QAD.0000000000000834.","journal-title":"AIDS"},{"issue":"2","key":"6003_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.7861\/clinmedicine.16-2-189","volume":"16","author":"EE Page","year":"2016","unstructured":"Page EE, Nelson M. Hepatitis C and sex. Clin Med (Lond). 2016;16(2):189\u201392. https:\/\/doi.org\/10.7861\/clinmedicine.16-2-189.","journal-title":"Clin Med (Lond)"},{"issue":"10","key":"6003_CR22","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/QAD.0000000000001090","volume":"30","author":"AJ Schmidt","year":"2016","unstructured":"Schmidt AJ, Bremer V. Response to the calculation of population attributable fractions (PAFs) of risk factors for hepatitis C transmission. AIDS. 2016;30(10):1683\u20134. https:\/\/doi.org\/10.1097\/QAD.0000000000001090.","journal-title":"AIDS"},{"issue":"12","key":"6003_CR23","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1093\/cid\/ciz160","volume":"69","author":"C Ramiere","year":"2019","unstructured":"Ramiere C, Charre C, Miailhes P, Bailly F, Radenne S, Uhres AC, et al. Patterns of hepatitis C virus transmission in human immunodeficiency virus (HIV)-infected and HIV-negative men who have sex with men. Clin Infect Dis. 2019;69(12):2127\u201335. https:\/\/doi.org\/10.1093\/cid\/ciz160.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6003_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1080\/13691050802061673","volume":"10","author":"G Owen","year":"2008","unstructured":"Owen G. An \u2018elephant in the room\u2019? Stigma and hepatitis C transmission among HIV-positive \u2018serosorting\u2019 gay men. Cult Health Sex. 2008;10(6):601\u201310. https:\/\/doi.org\/10.1080\/13691050802061673.","journal-title":"Cult Health Sex"},{"key":"6003_CR25","doi-asserted-by":"publisher","unstructured":"Hasse B, Ledergerber B, Hirschel B, Vernazza P, Glass TR, Jeannin A, et al. Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis. 2010;51(11):1314\u201322. https:\/\/doi.org\/10.1086\/656809.","DOI":"10.1086\/656809"},{"issue":"2","key":"6003_CR26","doi-asserted-by":"publisher","first-page":"ofv077","DOI":"10.1093\/ofid\/ofv077","volume":"2","author":"RD Kouyos","year":"2015","unstructured":"Kouyos RD, Hasse B, Calmy A, Cavassini M, Furrer H, Stockle M, et al. Increases in Condomless Sex in the Swiss HIV Cohort Study. Open Forum Infect Dis. 2015;2(2):ofv077.","journal-title":"Open Forum Infect Dis"},{"key":"6003_CR27","volume-title":"16th Euroepean AIDS Conference","author":"D Nicca","year":"2017","unstructured":"Nicca D, Fierz K, N\u00f6stlinger C, K\u00fcnzler-Heule P, Langewitz W, Schmidt AJ, et al. Doing the impossible: An e-health assisted counseling intervention to reduce risk in HCV-reinfection in men who have sex with men. In: 16th Euroepean AIDS Conference. Milan: European AIDS Clinical Society (EACS); 2017."},{"issue":"4","key":"6003_CR28","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/heapro\/dav061","volume":"31","author":"C N\u00f6stlinger","year":"2016","unstructured":"N\u00f6stlinger C, Borms R, Dec-Pietrowska J, Dias S, Rojas D, Platteau T, et al. Eurosupport 6 study group: development of a theory-guided pan-European computer-assisted safer sex intervention. Health Promot Int. 2016;31(4):782\u201392. https:\/\/doi.org\/10.1093\/heapro\/dav061.","journal-title":"Health Promot Int"},{"issue":"9","key":"6003_CR29","doi-asserted-by":"publisher","first-page":"e19100","DOI":"10.2196\/19100","volume":"4","author":"T Prinsenberg","year":"2020","unstructured":"Prinsenberg T, Zantkuijl P, Zuilhof W, Davidovich U, Schinkel J, Prins M, et al. Design and implementation of a multilevel intervention to reduce hepatitis C transmission among men who have sex with men in Amsterdam: co-creation and usability study. JMIR Form Res. 2020;4(9):e19100. https:\/\/doi.org\/10.2196\/19100.","journal-title":"JMIR Form Res"},{"issue":"2","key":"6003_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101. https:\/\/doi.org\/10.1191\/1478088706qp063oa.","journal-title":"Qual Res Psychol"},{"key":"6003_CR31","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V, Hayfield N, Terry G. Thematic Analysis. In: Liamputtong P, editor. Handbook of research methods in health social sciences: Springer Nature Singapore Pte Ltd. 2029: Springer Nature; 2019. p. 844\u201358.","DOI":"10.1007\/978-981-10-5251-4_103"},{"key":"6003_CR32","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jbi.2015.06.006","volume":"56","author":"L Mamykina","year":"2015","unstructured":"Mamykina L, Smaldone AM, Bakken SR. Adopting the sensemaking perspective for chronic disease self-management. J Biomed Inform. 2015;56:406\u201317. https:\/\/doi.org\/10.1016\/j.jbi.2015.06.006.","journal-title":"J Biomed Inform"},{"key":"6003_CR33","unstructured":"Weick KE: Sensemaking in organizations, Sage; vol. 3: 1995."},{"key":"6003_CR34","first-page":"118","volume-title":"Handbook of qualitative research","author":"TA Schwandt","year":"1994","unstructured":"Schwandt TA. Constructivist, interpretivist approaches to human inquiry. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Thousand Oaks: Sage Publications; 1994. p. 118\u201337."},{"key":"6003_CR35","doi-asserted-by":"publisher","DOI":"10.4324\/9781315426259","volume-title":"Interpretive description - qualitative research for applied practice","author":"S Thorne","year":"2016","unstructured":"Thorne S. Interpretive description - qualitative research for applied practice, vol. 2. New York and London: Routledge; 2016."},{"issue":"4","key":"6003_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/cid\/ciy547","volume":"68","author":"DL Braun","year":"2019","unstructured":"Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, et al. High cure rates with Grazoprevir-Elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus\/hepatitis C virus-coinfected men who have sex with men. Clin Infect Dis. 2019;68(4):569\u201376. https:\/\/doi.org\/10.1093\/cid\/ciy547.","journal-title":"Clin Infect Dis"},{"key":"6003_CR37","volume-title":"Swiss HCVree Trial","author":"DL Braun","year":"2016","unstructured":"Braun DL. Swiss HCVree Trial, vol. 2020: Clinical Trials.gov; 2016."},{"issue":"1","key":"6003_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1186\/s12879-019-4456-7","volume":"19","author":"P K\u00fcnzler-Heule","year":"2019","unstructured":"K\u00fcnzler-Heule P, Engberg S, Battegay M, Schmidt AJ, Fierz K, Nguyen H, et al. Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis. BMC Infect Dis. 2019;19(1):821. https:\/\/doi.org\/10.1186\/s12879-019-4456-7.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"6003_CR39","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/fampra\/13.6.522","volume":"13","author":"MN Marshall","year":"1996","unstructured":"Marshall MN. Sampling for qualitative research. Fam Pract. 1996;13(6):522\u20135. https:\/\/doi.org\/10.1093\/fampra\/13.6.522.","journal-title":"Fam Pract"},{"issue":"3","key":"6003_CR40","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1037\/0278-6133.14.3.255","volume":"14","author":"WA Fisher","year":"1995","unstructured":"Fisher WA, Fisher JD, Rye BJ. Understanding and promoting AIDS-preventive behavior: insights from the theory of reasoned action. Health Psychol. 1995;14(3):255\u201364. https:\/\/doi.org\/10.1037\/0278-6133.14.3.255.","journal-title":"Health Psychol"},{"key":"6003_CR41","doi-asserted-by":"publisher","unstructured":"N\u00f6stlinger C, Niderost S, Platteau T, Muller MC, Stanekova D, Gredig D, Roulin C, Rickenbach M, Colebunders R, Swiss HIV Cohort Study et al: Sexual protection behavior in HIV-positive gay men: testing a modified information-motivation-behavioral skills model. Arch Sex Behav 2011, 40(4):817\u2013827, DOI: https:\/\/doi.org\/10.1007\/s10508-010-9682-4.","DOI":"10.1007\/s10508-010-9682-4"},{"key":"6003_CR42","volume-title":"Social Foundations of Thought and Action: A Social Cognitive Theory","author":"A Bandura","year":"1986","unstructured":"Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs: Prentice-Hall; 1986."},{"issue":"10","key":"6003_CR43","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/13691058.2013.809478","volume":"15","author":"JY Le Talec","year":"2013","unstructured":"Le Talec JY. When \u2018raw sex\u2019 turns to a \u2018raw deal\u2019 ... taking the opportunity to think about sex? Interviews with HIV-positive gay men diagnosed with acute hepatitis C. Cult Health Sex. 2013;15(10):1133\u201347. https:\/\/doi.org\/10.1080\/13691058.2013.809478.","journal-title":"Cult Health Sex"},{"issue":"5","key":"6003_CR44","doi-asserted-by":"publisher","first-page":"e25288","DOI":"10.1002\/jia2.25288","volume":"22","author":"SE Schroeder","year":"2019","unstructured":"Schroeder SE, Higgs P, Winter R, Brown G, Pedrana A, Hellard M, et al. Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia. J Int AIDS Soc. 2019;22(5):e25288. https:\/\/doi.org\/10.1002\/jia2.25288.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"6003_CR45","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1186\/s12879-018-3571-1","volume":"18","author":"F Lambers","year":"2018","unstructured":"Lambers F, van der Veldt W, Prins M, Davidovich U. Mosaic study: changing the odds: motives for and barriers to reducing HCV-related sexual risk behaviour among HIV-infected MSM previously infected with HCV. BMC Infect Dis. 2018;18(1):678. https:\/\/doi.org\/10.1186\/s12879-018-3571-1.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6003_CR46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s41124-018-0036-5","volume":"3","author":"JA Richmond","year":"2018","unstructured":"Richmond JA, Ellard J, Wallace J, Thorpe R, Higgs P, Hellard M, et al. Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia. Hepatol Med Policy. 2018;3(1):8. https:\/\/doi.org\/10.1186\/s41124-018-0036-5.","journal-title":"Hepatol Med Policy"},{"issue":"1","key":"6003_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4278\/0890-1171-12.1.38","volume":"12","author":"JO Prochaska","year":"1997","unstructured":"Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38\u201348. https:\/\/doi.org\/10.4278\/0890-1171-12.1.38.","journal-title":"Am J Health Promot"},{"issue":"apr27 2","key":"6003_CR48","doi-asserted-by":"publisher","first-page":"c1900","DOI":"10.1136\/bmj.c1900","volume":"340","author":"S Rollnick","year":"2010","unstructured":"Rollnick S, Butler CC, Kinnersley P, Gregory J, Mash B. Motivational ienterviewing. BMJ. 2010;340(apr27 2):c1900.","journal-title":"BMJ"},{"issue":"2","key":"6003_CR49","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/j.pec.2010.11.009","volume":"85","author":"DJ Cohen","year":"2011","unstructured":"Cohen DJ, Clark EC, Lawson PJ, Casucci BA, Flocke SA. Identifying teachable moments for health behavior counseling in primary care. Patient Educ Couns. 2011;85(2):e8\u201315. https:\/\/doi.org\/10.1016\/j.pec.2010.11.009.","journal-title":"Patient Educ Couns"},{"issue":"1","key":"6003_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.pec.2008.11.002","volume":"76","author":"PJ Lawson","year":"2009","unstructured":"Lawson PJ, Flocke SA. Teachable moments for health behavior change: a concept analysis. Patient Educ Couns. 2009;76(1):25\u201330. https:\/\/doi.org\/10.1016\/j.pec.2008.11.002.","journal-title":"Patient Educ Couns"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-06003-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T11:05:26Z","timestamp":1617707126000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,6]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6003"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06003-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,6]]},"assertion":[{"value":"12 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The <i>Swiss HCVree Trial<\/i> was approved by the lead ethic committee in Zurich, Switzerland () under the reference number BASEC 2016\u201300131 (locally responsible for the University Hospital Zurich and Klinik im Park). Local ethics committee Bern (University Hospital Bern), Northwest\/Central (EKNZ) (University Hospital Basel), Geneva (University Hospital of Geneva), Ostschweiz (EKOS) (Cantonal Hospital St. Gallen), Ticino (Regional Hospital Lugano), and Vaud (University Hospital Center Lausanne) approved as well. The study was carried out in accordance with principles enunciated in the current version of the Declaration of Helsinki, the guidelines of Good Clinical Practice (GCP) issued by ICH, and Swiss competent authority\u2019s requirements.All participants provided written informed consent prior to participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PKH received consultancy fees from Eisai, and grants from ViiV, Merck, and Janssen; all outside the submitted work.KF has no conflict of interest.AJS has no conflict of interest.MR has no conflict of interest.JB has no conflict of interest.AK reports grant from Merck outside submitted work.SE has no conflict of interest.MB has no conflict of interest.CN has no conflict of interest.AL has no conflict of interest.RK has no conflict of interest.PS received travel grants from Merck, outside submitted work.DLB received consultancy fees from Merck, Gilead, and ViiV.JF is a member of the Federal Commission for Sexual Health. He received research, educational and travel grants from Janssen, Merck and ViiV Healthcare.DN reports grants from Merck, Janssen, and ViiV outside submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}